Surgery Partners (NASDAQ:SGRY – Get Free Report) had its price target reduced by analysts at Macquarie from $34.00 to $33.00 in a research report issued on Tuesday,Benzinga reports. The firm currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback